4.6 Article

Identification of High-Risk of Recurrence in Clinical Stage I Non-Small Cell Lung Cancer

Related references

Note: Only part of the references are listed.
Article Cardiac & Cardiovascular Systems

Prognostic impact of a ground-glass opacity component in clinical stage IA non-small cell lung cancer

Aritoshi Hattori et al.

Summary: The study validated the prognostic importance of ground-glass opacity component in clinical stage IA lung cancer and recommended considering it as an important parameter in the next clinical T classification.

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2021)

Article Medicine, General & Internal

Preoperative nivolumab to evaluate pathological response in patients with stage I non-small cell lung cancer: a study protocol of phase II trial (POTENTIAL)

Atsushi Kagimoto et al.

Summary: The study aims to investigate the pathological response of preoperative nivolumab treatment for clinical stage I NSCLC patients and its effectiveness for high-risk patients. The trial plans to enroll 50 patients and started recruitment in April 2019.

BMJ OPEN (2021)

Article Cardiac & Cardiovascular Systems

Solid Tumor Size of 2 cm Divides Outcomes of Patients With Mixed Ground Glass Opacity Lung Tumors

Takahiro Mimae et al.

ANNALS OF THORACIC SURGERY (2020)

Article Cardiac & Cardiovascular Systems

Prediction of Lymph Node Metastasis Using Semiquantitative Evaluation of PET for Lung Adenocarcinoma

Atsushi Kagimoto et al.

ANNALS OF THORACIC SURGERY (2020)

Article Cardiac & Cardiovascular Systems

Prognostic Role of Positron Emission Tomography and High-Resolution Computed Tomography in Clinical Stage IA Lung Adenocarcinoma

Hirofumi Uehara et al.

ANNALS OF THORACIC SURGERY (2013)

Article Cardiac & Cardiovascular Systems

The ground glass opacity component can be eliminated from the T-factor assessment of lung adenocarcinoma

Tomohiro Murakawa et al.

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2013)

Article Cardiac & Cardiovascular Systems

The size of consolidation on thin-section computed tomography is a better predictor of survival than the maximum tumour dimension in resectable lung cancer

Tatsuo Maeyashiki et al.

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2013)

Article Cardiac & Cardiovascular Systems

The prognostic role of pathologic invasive component size, excluding lepidic growth, in stage I lung adenocarcinoma

Yasuhiro Tsutani et al.

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2013)

Article Medicine, General & Internal

Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening

Denise R. Aberle et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)